Pharmacokinetics and tolerability of cediranib, a potent VEGF signalling inhibitor, in cancer patients with hepatic impairment

Authors :: van Herpen, Carla M L
Lassen, Ulrik
Desar, Ingrid M E
Brown, Kathryn H
Marotti, Marcelo
de Jonge, Maja J A
van Herpen, Carla M L
Lassen, Ulrik
Desar, Ingrid M E
Brown, Kathryn H
Marotti, Marcelo
de Jonge, Maja J A
Source :: van Herpen , C M L , Lassen , U , Desar , I M E , Brown , K H , Marotti , M & de Jonge , M J A 2013 , ' Pharmacokinetics and tolerability of cediranib, a potent VEGF signalling inhibitor, in cancer patients with hepatic impairment ' , Anti-Cancer Drugs , vol. 24 , no. 2 , pp. 204-11 .
Publication Year :: 2013

Database :: OAIster
Journal :: van Herpen , C M L , Lassen , U , Desar , I M E , Brown , K H , Marotti , M & de Jonge , M J A 2013 , ' Pharmacokinetics and tolerability of cediranib, a potent VEGF signalling inhibitor, in cancer patients with hepatic impairment ' , Anti-Cancer Drugs , vol. 24 , no. 2 , pp. 204-11 .
Notes :: English
Publication Type :: Electronic Resource
Accession number :: edsoai.on1322650184
Document Type :: Electronic Resource

Tools